Audubon-based Globus Medical has announced its acquisition of California life sciences company Nevro Corp. for $250 million ...

Stryker sold its U.S. spinal implants to the Viscogliosi Brothers, and market analysts with GlobalData predict the move will benefit competitors in spinal fusio ...

Globus Medical GMED has entered into a definitive agreement to acquire Nevro Corp. NVRO in an all-cash transaction valued at approximately $250 million. Under the terms of the agreement, unanimously ...

Globus Medical (GMED) has agreed to buy Nevro (NVRO) through an all-cash deal valued at around $250M. Read more here.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Analyst Ryan Zimmerman from BTIG maintained a Buy rating on Globus Medical (GMED – Research Report) and keeping the price target at $91.00. Ryan Zimmerman’s rating is based on a combination of ...

The company’s electrophysiology segment reported $2.47 billion in sales in 2024, for year-over-year growth of ... “Structural heart represents one of the most attractive areas in the field of medical ...

The company currently has its sales operations distributed across 51 counties worldwide. With the complementary strengths of Globus Medical engineering and NuVasive relations, education and ...